Clinical trials: Recovery Following Partial Medial Meniscectomy
Recovery Following Partial Medial Meniscectomy
Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy
The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).
- Trial name
- NCT00702741
- Testing
- Chondrogen
- Where
- 4 sites in United States
- Volunteers
- 55 people
- Sponsor
- Mesoblast International Sàrl
Recovery Following Partial Medial Meniscectomy
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
The purpose of this study is to determine whether Chondrogen is a safe and effective post-operative treatment of the knee following menisectomy (the surgical removal of all or part of a torn meniscus).
- Trial name
- NCT00225095
- Testing
- Mesenchymal Stem Cells, Hyaluronan
- Where
- 8 sites in United States
- Volunteers
- 60 people
- Sponsor
- Mesoblast International Sàrl